These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 63293)

  • 21. Correlation of structure and activity in ansamycins: structure, conformation, and interactions of antibiotic rifamycin S.
    Arora SK
    J Med Chem; 1985 Aug; 28(8):1099-102. PubMed ID: 4020831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of isolated yeast and mycelial phase RNA polymerases of Histoplasma capsulatum by rifamycin derivatives.
    McMillian R; Medoff G; Schlessinger D; Kobayashi GS
    Sabouraudia; 1977 Nov; 15(3):257-61. PubMed ID: 601661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxygen Enhancement of bactericidal activity of rifamycin SV on Escherichia coli and aerobic oxidation of rifamycin SV to rifamycin S catalyzed by manganous ions: the role of superoxide.
    Kono Y
    J Biochem; 1982 Jan; 91(1):381-95. PubMed ID: 6279585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detergent effects on a reverse transcriptase activity and on inhibition by rifamycin derivatives.
    Thompson FM; Libertini LJ; Joss UR; Calvin M
    Science; 1972 Nov; 178(4060):505-7. PubMed ID: 4116919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of action of a rifamycin derivative (AF-013) which is active on the nucleic acid polymerases insensitive to rifampicin.
    Riva S; Fietta A; Silvestri LG
    Biochem Biophys Res Commun; 1972 Dec; 49(5):1263-71. PubMed ID: 4566674
    [No Abstract]   [Full Text] [Related]  

  • 26. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.
    Vavricka SR; Van Montfoort J; Ha HR; Meier PJ; Fattinger K
    Hepatology; 2002 Jul; 36(1):164-72. PubMed ID: 12085361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of purified ribonucleic acid directed deoxyribonucleic acid polymerase of avian myeloblastosis virus and murine sarcoma-leukemia virus with a rifamycin SV derivative.
    Gurgo C; Grandgenett DP; Gerad GF; Green M
    Biochemistry; 1974 Feb; 13(4):708-13. PubMed ID: 4129863
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative study of the effect of different rifamycins on bacterial cell metabolism and on the RNA-polymerase reaction in a cell-free system].
    Subbotina NA
    Antibiotiki; 1978 Mar; 23(3):239-42. PubMed ID: 345958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A derivative of rifamycin SV inhibiting rifampicin-resistant RNA polymerase of Escherichia coli.
    Nikiforov VG; Trapkova AA; Gragerov AI; Maslin DN
    FEBS Lett; 1982 Dec; 150(2):416-8. PubMed ID: 6761147
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition by rifamycin AF/013 of thyroid hormone binding to the nuclear receptor.
    Inoue A; Higashi Y; Yukioka M; Morisawa S
    J Biochem; 1987 Dec; 102(6):1365-70. PubMed ID: 3448087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and purification of RNA polymerases from rye embryos.
    Fabisz-Kijowska A; Dullin P; Walerych W
    Biochim Biophys Acta; 1975 Apr; 390(1):105-16. PubMed ID: 1125311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of ansamycin inhibition of a ribonucleic acid-directed deoxyribonucleic acid polymerase by an immobilized template assay.
    Milavetz BI; Horoszewicz JS; Rinehart KL; Carter WA
    Antimicrob Agents Chemother; 1978 Mar; 13(3):435-40. PubMed ID: 95661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Base specificity in the inhibition of oncornavirus reverse transcriptase and cellular nucleic acid polymerases by antitumor drugs.
    Sethi VS
    Ann N Y Acad Sci; 1977 Mar; 284():508-24. PubMed ID: 81641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-(Carboxyalkylthio) rifamycin S and SV derivatives inhibit human neutrophil functions.
    Spisani S; Traniello S; Onori AM; Rizzuti O; Martuccio C; Cellai L
    Inflammation; 1998 Oct; 22(5):459-69. PubMed ID: 9793793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Enzymes of the Rifamycin Antibiotic Resistome.
    Surette MD; Spanogiannopoulos P; Wright GD
    Acc Chem Res; 2021 May; 54(9):2065-2075. PubMed ID: 33877820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [RNA polymerase-rifamycin. A molecular model of inhibition].
    Chertov OIu; Obukhov AN; Lipkin VM
    Bioorg Khim; 1983 May; 9(5):633-40. PubMed ID: 6207842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of T7 specific RNA polymerase. 3. Inhibition by derivatives of rifamycin SV.
    Chamberlin MJ; Ring J
    Biochem Biophys Res Commun; 1972 Nov; 49(4):1129-36. PubMed ID: 4641709
    [No Abstract]   [Full Text] [Related]  

  • 38. Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2.
    Fattinger K; Cattori V; Hagenbuch B; Meier PJ; Stieger B
    Hepatology; 2000 Jul; 32(1):82-6. PubMed ID: 10869292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [DNA polymerases of RNA tumor virus (RNA-DNA reaction)].
    Fujinaga K
    Tanpakushitsu Kakusan Koso; 1973 Jan; 18(1):18-34. PubMed ID: 4119450
    [No Abstract]   [Full Text] [Related]  

  • 40. Mitochondrial poly(A) polymerase from a poorly differentiated hepatoma: purification and characteristics.
    Rose KM; Morris HP; Jacob ST
    Biochemistry; 1975 Mar; 14(5):1025-32. PubMed ID: 235943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.